Celgene Corporation (CELG) and Abraxis BioScience, Inc. Announce Shareholder Vote in Favor of Merger  
10/14/2010 7:57:35 AM

SUMMIT, N.J. & LOS ANGELES--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) and Abraxis Bioscience, Inc. (NASDAQ: ABII) today announced that Abraxis’ shareholders approved the merger agreement between the companies. The companies anticipate the closing of the transaction will occur on October 15, 2010.